Cargando…
Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells
BACKGROUND: Metformin has been reported to function as the anti-tumor inhibiting the growth of different types of cancers, including bladder cancer. But there are few reports on the roles of Yap1, the key molecule of Hippo pathway, in the metformin induced inhibition of bladder cancer (BLCA). We are...
Autores principales: | Wu, Yanju, Zheng, Qianqian, Li, Yan, Wang, Guang, Gao, Shuting, Zhang, Xiaodong, Yan, Xu, Zhang, Xinwen, Xie, Jisheng, Wang, Yuanyuan, Sun, Xun, Meng, Xin, Yin, Bo, Wang, Biao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712726/ https://www.ncbi.nlm.nih.gov/pubmed/31455378 http://dx.doi.org/10.1186/s13046-019-1346-1 |
Ejemplares similares
-
Gatekeepers of pancreas: TEAD and YAP
por: Rodríguez-Seguí, Santiago A., et al.
Publicado: (2015) -
RGS12 is a novel tumor suppressor in osteosarcoma that inhibits YAP-TEAD1-Ezrin signaling
por: Li, Yang, et al.
Publicado: (2021) -
Identification of Celastrol as a Novel YAP-TEAD Inhibitor for Cancer Therapy by High Throughput Screening with Ultrasensitive YAP/TAZ–TEAD Biosensors
por: Nouri, Kazem, et al.
Publicado: (2019) -
Repurposing of Drugs Targeting YAP-TEAD Functions
por: Elisi, Gian Marco, et al.
Publicado: (2018) -
A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness
por: Pegoraro, Silvia, et al.
Publicado: (2015)